Ian Read, executive chair for the pharmaceutical company, said Gottlieb's "expertise in health care, public policy, and the industry will be an asset" to the company, in today's bite-sized hospital and health industry news from California, Minnesota, and New York.
- California: A California federal court has scheduled a criminal trial to begin in summer 2020 for former Theranos CEO Elizabeth Holmes. Holmes has been accused of defrauding investors, patients, and doctors about the capabilities of her blood-testing technology. Federal prosecutors and defense attorneys in a pretrial hearing in a federal court in California on Friday agreed to begin jury selection the week of July 28, 2020. They are set to hear opening arguments on Aug. 4, 2020. The trial should last for about three months, according to STAT News (Robbins, STAT News, 6/28).
- Minnesota: UnitedHealth Group on Friday announced that it will be debuting a new executive team following the retirement of UnitedHealthcare CEO Steve Nelson, effective immediately. Dirk McMahon, president and COO of Optum, will take over Nelson's role as UnitedHealthcare CEO. Additionally, Daniel Schumacher, who currently is president and COO of UnitedHealthcare, will take over as president and COO of Optum. (Daily Briefing is published by Advisory Board, a division of Optum, which is a wholly owned subsidiary of UnitedHealth Group. UnitedHealth Group separately owns UnitedHealthcare) (Haefner, Becker's Hospital Review, 6/28; Porter, HealthLeaders Media, 6/28; UnitedHealth Group release, 6/28).
- New York: Pfizer announced Friday that former FDA commissioner Scott Gottlieb will be joining its board of directors. Ian Read, executive chair for the pharmaceutical company, said Gottlieb's "expertise in health care, public policy, and the industry will be an asset" to the company. Leigh Turner, a bioethicist, criticized the move, saying it could "harm the reputation of the FDA," and "reinforces concerns that there is too cozy a relationship between the FDA and the companies it is supposed to regulate" (McGinley, Washington Post, 6/28).